BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26694149)

  • 1. Increasing bioavailability of (R)-alpha-lipoic acid to boost antioxidant activity in the treatment of neuropathic pain.
    Maglione E; Marrese C; Migliaro E; Marcuccio F; Panico C; Salvati C; Citro G; Quercio M; Roncagliolo F; Torello C; Brufani M
    Acta Biomed; 2015 Dec; 86(3):226-33. PubMed ID: 26694149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (R)-α-lipoic acid oral liquid formulation: pharmacokinetic parameters and therapeutic efficacy.
    Brufani M; Figliola R
    Acta Biomed; 2014 Aug; 85(2):108-15. PubMed ID: 25245645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights on the Use of α-Lipoic Acid for Therapeutic Purposes.
    Salehi B; Berkay Yılmaz Y; Antika G; Boyunegmez Tumer T; Fawzi Mahomoodally M; Lobine D; Akram M; Riaz M; Capanoglu E; Sharopov F; Martins N; Cho WC; Sharifi-Rad J
    Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31405030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha lipoic acid and superoxide dismutase in the treatment of chronic low back pain.
    Battisti E; Albanese A; Guerra L; Argnani L; Giordano N
    Eur J Phys Rehabil Med; 2013 Oct; 49(5):659-64. PubMed ID: 23860422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single dose bioavailability and pharmacokinetic study of a innovative formulation of α-lipoic acid (ALA600) in healthy volunteers.
    Mignini F; Capacchietti M; Napolioni V; Reggiardo G; Fasani R; Ferrari P
    Minerva Med; 2011 Dec; 102(6):475-82. PubMed ID: 22193379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of an R-α-Lipoic Acid/γ-Cyclodextrin Complex in Healthy Volunteers.
    Ikuta N; Okamoto H; Furune T; Uekaji Y; Terao K; Uchida R; Iwamoto K; Miyajima A; Hirota T; Sakamoto N
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27314343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of α-lipoic acid in diabetic neuropathy.
    Papanas N; Ziegler D
    Expert Opin Pharmacother; 2014 Dec; 15(18):2721-31. PubMed ID: 25381809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic study of lipoic acid in multiple sclerosis: comparing mice and human pharmacokinetic parameters.
    Yadav V; Marracci GH; Munar MY; Cherala G; Stuber LE; Alvarez L; Shinto L; Koop DR; Bourdette DN
    Mult Scler; 2010 Apr; 16(4):387-97. PubMed ID: 20150394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant properties of an endogenous thiol: Alpha-lipoic acid, useful in the prevention of cardiovascular diseases.
    Ghibu S; Richard C; Vergely C; Zeller M; Cottin Y; Rochette L
    J Cardiovasc Pharmacol; 2009 Nov; 54(5):391-8. PubMed ID: 19998523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantioselective Pharmacokinetics of α-Lipoic Acid in Rats.
    Uchida R; Okamoto H; Ikuta N; Terao K; Hirota T
    Int J Mol Sci; 2015 Sep; 16(9):22781-94. PubMed ID: 26402669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations on the pharmacokinetics of alpha-lipoic acid in healthy volunteers.
    Teichert J; Kern J; Tritschler HJ; Ulrich H; Preiss R
    Int J Clin Pharmacol Ther; 1998 Dec; 36(12):625-8. PubMed ID: 9876998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of oral alpha-lipoic acid treatment in pregnant women: a retrospective observational study.
    Parente E; Colannino G; Picconi O; Monastra G
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4219-4227. PubMed ID: 29028075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease.
    Maczurek A; Hager K; Kenklies M; Sharman M; Martins R; Engel J; Carlson DA; Münch G
    Adv Drug Deliv Rev; 2008; 60(13-14):1463-70. PubMed ID: 18655815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-lipoic acid may improve symptomatic diabetic polyneuropathy.
    Tang J; Wingerchuk DM; Crum BA; Rubin DI; Demaerschalk BM
    Neurologist; 2007 May; 13(3):164-7. PubMed ID: 17495764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-lipoic acid supplementation and diabetes.
    Singh U; Jialal I
    Nutr Rev; 2008 Nov; 66(11):646-57. PubMed ID: 19019027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic applications of lipoic acid: a patent review (2011 - 2014).
    Koufaki M
    Expert Opin Ther Pat; 2014 Sep; 24(9):993-1005. PubMed ID: 25101925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-lipoic acid and cardiovascular disease.
    Wollin SD; Jones PJ
    J Nutr; 2003 Nov; 133(11):3327-30. PubMed ID: 14608040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alpha-tocopherol and alpha-lipoic acid. An antioxidant synergy with potential for preventive medicine].
    González-Pérez O; Moy-López NA; Guzmán-Muñiz J
    Rev Invest Clin; 2008; 60(1):58-67. PubMed ID: 18589588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with thioctacid (thioctic acid) in the treatment of distal symmetric polyneuropathy in Korean diabetic patients.
    Hahm JR; Kim BJ; Kim KW
    J Diabetes Complications; 2004; 18(2):79-85. PubMed ID: 15120701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of alpha lipoic acid derivatives to treat multiple sclerosis-associated central neuropathic pain.
    Kong D; Saqer AA; Carpinelli de Jesus M; Khan N; Jones A; Blanchfield JT; Smith MT; Williams CM
    Bioorg Med Chem; 2022 Sep; 69():116889. PubMed ID: 35779512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.